BRAF and neoplasm: To determine whether the tumor suppressor signature and the inhibition of EMT associated with ZEB1 in Braf-mutant mouse models also occurred in patients with CRC, we retrospectively analyzed 41 BRAF-mutant mCRC according to their ZEB1 expression (Supplemental Table 4).